← All trials
NCT04373707
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 13, 2020
- Primary completion
- Sep 30, 2020
- Completion date
- Oct 31, 2020
- First posted
- May 4, 2020
- Last posted
- May 14, 2020
- Enrollment
- 602
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of LorraineLead sponsor
- Jean Monnet UniversityCollaborator
- Government of FranceCollaborator
- University of LorraineOverall official - principal investigator
- Grand Est RegionCollaborator
- Polyclinique d'oncologie de Gentilly, Nancy, FranceStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.